Anika Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Anika Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q4 2024.
  • Anika Therapeutics, Inc. Goodwill for the quarter ending December 31, 2024 was $7.13M, a 5.89% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $7.13M -$446K -5.89% Dec 31, 2024 10-K 2025-03-17
Q3 2024 $7.66M +$403K +5.56% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $7.35M -$117K -1.57% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.4M -$59K -0.79% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $7.57M +$232K +3.16% Dec 31, 2023 10-K 2025-03-17
Q3 2023 $7.25M +$532K +7.92% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $7.47M +$298K +4.16% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $7.46M -$163K -2.14% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $7.34M -$442K -5.68% Dec 31, 2022 10-K 2025-03-17
Q3 2022 $6.72M -$1.23M -15.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $7.17M -$980K -12% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $7.63M -$420K -5.22% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $7.78M -$632K -7.51% Dec 31, 2021 10-K 2024-03-15
Q3 2021 $7.95M -$24.5M -75.5% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $8.15M -$25.8M -76% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $8.05M -$25.8M -76.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $8.41M +$719K +9.35% Dec 31, 2020 10-K 2023-03-16
Q3 2020 $32.4M +$24.9M +333% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $34M +$26.2M +335% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $33.8M +$26.1M +339% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $7.69M -$157K -2% Dec 31, 2019 10-K 2022-03-11
Q3 2019 $7.49M -$470K -5.91% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $7.8M -$215K -2.68% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $7.69M -$758K -8.97% Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $7.85M -$367K -4.47% Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $7.96M -$145K -1.79% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $8.01M +$177K +2.26% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $8.45M +$1.12M +15.3% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $8.22M +$1M +13.9% Dec 31, 2017 10-K 2020-03-06
Q3 2017 $8.1M +$414K +5.38% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $7.84M +$268K +3.54% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $7.33M -$462K -5.93% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $7.21M -$268K -3.58% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $7.69M -$23K -0.3% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $7.57M -$42.8K -0.56% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $7.79M +$347K +4.66% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $7.48M -$857K -10.3% Dec 31, 2015 10-K 2018-02-27
Q3 2015 $7.71M -$989K -11.4% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $7.61M -$1.75M -18.7% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $7.44M -$1.99M -21.1% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $8.34M -$1.11M -11.7% Dec 31, 2014 10-K 2017-02-24
Q3 2014 $8.7M -$573K -6.18% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $9.36M +$438K +4.91% Jun 30, 2014 10-Q 2014-11-06
Q1 2014 $9.43M +$642K +7.3% Mar 31, 2014 10-Q 2014-08-04
Q4 2013 $9.44M +$378K +4.17% Dec 31, 2013 10-K 2016-03-10
Q3 2013 $9.28M $0 0% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $8.92M +$296K +3.43% Jun 30, 2013 10-Q 2013-11-05
Q1 2013 $8.79M -$358K -3.91% Mar 31, 2013 10-Q 2013-08-06
Q4 2012 $9.07M $0 0% Dec 31, 2012 10-K 2015-03-13
Q3 2012 $9.28M -$52.8K -0.57% Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $8.63M -$1.24M -12.6% Jun 30, 2012 10-Q 2012-11-08
Q1 2012 $9.15M Mar 31, 2012 10-Q 2012-08-07
Q4 2011 $9.07M -$26.1K -0.29% Dec 31, 2011 10-Q 2013-11-05
Q3 2011 $9.33M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $9.87M Jun 30, 2011 10-Q/A 2011-08-10
Q4 2010 $9.09M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.